AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PLUS THERAPEUTICS, INC. Director's Dealing 2025

Aug 15, 2025

34301_dirs_2025-08-15_e2fc9e56-eb18-48bc-bdc8-5c1b15a09560.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2025-04-18

Reporting Person: Guse Kyle (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct